Screening for Anthrax Postexposure Antibiotic Prophylaxis-The New York City Approach

Health Secur. 2018 Jul/Aug;16(4):274-279. doi: 10.1089/hs.2018.0025.

Abstract

Individuals exposed to spores of B. anthracis must take a course of antibiotics as postexposure prophylaxis (PEP) to prevent inhalation anthrax. During an anthrax event, public health authorities are responsible for conducting dispensing operations to offer PEP to exposed individuals. Jurisdictions have developed antibiotic PEP screening algorithms to determine which antibiotic is appropriate for each individual. Variability exists with regard to screening questions and dispensing decisions based on responses to those questions. It is likely that individuals with similar profiles will receive different antibiotics based solely on the jurisdiction in which they receive their PEP. This lack of consistency among jurisdictions may lead to a loss of confidence in the public health response among the public, the healthcare community, the media, and government leaders, which could compromise the response itself. We present New York City's planning assumptions, screening algorithm, a rationale for our screening questions, and our reasons for excluding screening questions asked by other jurisdictions. We hope that our efforts may assist others in developing and refining their algorithms and associated public messaging and encourage standardization with neighboring jurisdictions where appropriate.

MeSH terms

  • Anthrax / prevention & control*
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis / standards*
  • Bacillus anthracis
  • Guidelines as Topic*
  • Humans
  • New York City
  • Post-Exposure Prophylaxis / standards*
  • Respiratory Tract Infections / prevention & control*

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • Inhalation anthrax